A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety of TOL-3021 in Patients With New Onset or Established Type 1 Diabetes Mellitus - ICH GCP - Clinical Trials Registry